Marshall Wace North America’s Accendra Health ACH Stock Holding History

Marshall Wace North America’s Portfolio ACH Stock Details ACH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-58,785	Closed	-$2.21M	–	1671
2021 Q1	$2.21M	Sell	58,785 -4,140	-7%	-$129K	0.01%	802
2020 Q4	$1.7M	Buy	+62,925	New	+$1.62M	0.01%	800
2020 Q2	–	Sell	-165,101	Closed	-$1.51M	–	1381
2020 Q1	$1.51M	Buy	165,101 +130,928	+383%	+$790K	0.01%	536
2019 Q4	$177K	Buy	+34,173	New	+$219K	﹤0.01%	991
2019 Q3	–	Sell	-138,700	Closed	-$444K	–	1474
2019 Q2	$444K	Buy	+138,700	New	+$473K	﹤0.01%	915
2018 Q1	–	Sell	-21,360	Closed	-$403K	–	1619
2017 Q4	$403K	Buy	+21,360	New	+$474K	﹤0.01%	1185

Other funds holding ACH

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Marshall Wace North America's ACH Position: Q2 2021 in Review

Marshall Wace North America sold out of Accendra Health (ACH) in Q2 2021, closing a stake of 58,785 shares — an estimated $2.21M sold.

Marshall Wace North America first reported a position in ACH in Q4 2017 and held it in 6 quarters. The position peaked at $2.21M in Q1 2021. 260 funds tracked by Wall St. Rank hold ACH as of Q2 2021.

Marshall Wace North America reported no remaining Accendra Health position as of Q2 2021 after selling out during the quarter.
Marshall Wace North America sold 58,785 Accendra Health shares in Q2 2021, an estimated $2.21M.
Marshall Wace North America first reported a position in Accendra Health in Q4 2017 and held it in 6 quarters.
Marshall Wace North America's Accendra Health position peaked at $2.21M in Q1 2021.
260 funds tracked by Wall St. Rank held Accendra Health as of Q2 2021.

Based on Marshall Wace North America's 13F filing for Q2 2021, filed 13 Aug 2021.